Implications of the UKPDS Study for general practice care of type 2 diabetes.
Brankin
E
E
Fisher
M
M
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005194:Family Practice; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D006113:United Kingdom
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents